Anna Carbó

445 total citations
9 papers, 32 citations indexed

About

Anna Carbó is a scholar working on Oncology, Immunology and Reproductive Medicine. According to data from OpenAlex, Anna Carbó has authored 9 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Immunology and 3 papers in Reproductive Medicine. Recurrent topics in Anna Carbó's work include Cutaneous Melanoma Detection and Management (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Anna Carbó is often cited by papers focused on Cutaneous Melanoma Detection and Management (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Anna Carbó collaborates with scholars based in Spain, Palestinian Territory and United States. Anna Carbó's co-authors include Jordi Rubió‐Casadevall, Rafael Marcos‐Gragera, Montse Puigdemont, Glòria Oliveras, Bernat del Olmo, L. Vilardell, Arantza Sanvisens, Mónica Coll, Gemma Osca‐Gelis and Aránzazu Manzano and has published in prestigious journals such as International Journal of Molecular Sciences, BMC Cancer and Cancers.

In The Last Decade

Anna Carbó

6 papers receiving 31 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Carbó Spain	4	25	11	9	5	4	9	32
Jessica M. Donigan United States	3	27 1.1×	10 0.9×	16 1.8×	7 1.4×	6 1.5×	6	40
Andreea Stefan France	3	19 0.8×	5 0.5×	15 1.7×	6 1.2×	3 0.8×	3	25
Ann‐Sophie Bohne Germany	4	22 0.9×	16 1.5×	6 0.7×	2 0.4×	4 1.0×	10	34
Lucy Navsaria United States	5	23 0.9×	7 0.6×	16 1.8×	7 1.4×		17	38
Nira A. Krasnow United States	4	53 2.1×	9 0.8×	6 0.7×	9 1.8×	4 1.0×	6	62
Neharika Khurana United States	3	24 1.0×	8 0.7×	4 0.4×	2 0.4×	3 0.8×	6	28
Jung-Yun Lee South Korea	4	17 0.7×	6 0.5×	8 0.9×		4 1.0×	12	29
Josip Skoko Germany	3	12 0.5×	14 1.3×	9 1.0×		3 0.8×	3	27
C. Moreno-Iribas Spain	6	51 2.0×	13 1.2×	17 1.9×	6 1.2×	22 5.5×	6	92
Sarah Hobelsberger Germany	4	22 0.9×	3 0.3×	13 1.4×	9 1.8×	2 0.5×	13	40

Countries citing papers authored by Anna Carbó

Since Specialization

Citations

This map shows the geographic impact of Anna Carbó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Carbó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Carbó more than expected).

Fields of papers citing papers by Anna Carbó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Carbó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Carbó. The network helps show where Anna Carbó may publish in the future.

Co-authorship network of co-authors of Anna Carbó

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Carbó. A scholar is included among the top collaborators of Anna Carbó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Carbó. Anna Carbó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Gallego, Alejandro, Ainhoa Madariaga, Anna Carbó, et al.. (2025). An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study). International Journal of Gynecological Cancer. 35(7). 101903–101903.

Rubio, María Jesús, Aránzazu Manzano, Purificación Estévez-García, et al.. (2024). Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study. BMC Cancer. 24(1). 803–803.

Plaja, Andrea, María Ochoa-de-Olza, Marc Cucurull, et al.. (2023). Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International Journal of Molecular Sciences. 24(14). 11420–11420. 3 indexed citations

Pardo, Marta, Esther Darder, Anna Carbó, et al.. (2023). Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study. Clinical & Translational Oncology. 26(4). 1033–1037.

Carbó, Anna, Jordi Rubió‐Casadevall, Montse Puigdemont, et al.. (2022). Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe. Cancers. 14(3). 780–780. 11 indexed citations

Rubió‐Casadevall, Jordi, et al.. (2021). Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor. European Journal of Dermatology. 31(5). 616–622. 6 indexed citations

Carbó, Anna, et al.. (2021). Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report. Case Reports in Oncology. 14(3). 1289–1294. 1 indexed citations

Roca-Barceló, Aina, Gemma Viñas, Anna Carbó, et al.. (2018). Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994–2013). Clinical & Translational Oncology. 21(7). 891–899. 3 indexed citations

Rubió‐Casadevall, Jordi, et al.. (2018). Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994–2013: a population-based study. Clinical & Translational Oncology. 20(12). 1617–1625. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact